Log in

OTCMKTS:IMRSQ - IMRIS Stock Price, Forecast & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume19,490 shs
Average Volume19,490 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta-1.94
IMRIS Inc designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). Read More…

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:IMRSQ
Previous SymbolNASDAQ:IMRS
CUSIPN/A
Phone763-203-6300

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees121
Next Earnings DateN/A
OptionableNot Optionable

Receive IMRSQ News and Ratings via Email

Sign-up to receive the latest news and ratings for IMRSQ and its competitors with MarketBeat's FREE daily newsletter.


IMRIS (OTCMKTS:IMRSQ) Frequently Asked Questions

What is IMRIS's stock symbol?

IMRIS trades on the OTCMKTS under the ticker symbol "IMRSQ."

Has IMRIS been receiving favorable news coverage?

Headlines about IMRSQ stock have been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. IMRIS earned a news impact score of -1.4 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for IMRIS.

Who are some of IMRIS's key competitors?

What other stocks do shareholders of IMRIS own?

Who are IMRIS's key executives?

IMRIS's management team includes the folowing people:
  • Mr. Maurice L. Holloman, Exec. VP of Operations - Customer Support & Customer Engineering
  • Mr. Andrew M. Flanagan, CEO & Pres
  • Mr. Robert C. Korn, Sr. VP of Global Sales and Marketing (Age 54)
  • Mr. Peter Simpson, Sr. VP of R&D

How do I buy shares of IMRIS?

Shares of IMRSQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is IMRIS's official website?

The official website for IMRIS is http://www.imris.com/.

How can I contact IMRIS?

IMRIS's mailing address is 5101 SHADY OAK RD, MINNETONKA MN, 55343. The company can be reached via phone at 763-203-6300 or via email at [email protected]


MarketBeat Community Rating for IMRIS (OTCMKTS IMRSQ)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  117 (Vote Outperform)
Underperform Votes:  119 (Vote Underperform)
Total Votes:  236
MarketBeat's community ratings are surveys of what our community members think about IMRIS and other stocks. Vote "Outperform" if you believe IMRSQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMRSQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/27/2020 by MarketBeat.com Staff

Featured Article: Beige Book

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel